Skip to main content
SpringerLink
Log in

Karzinoide

  • Chapter
Kompendium Internistische Onkologie

Zusammenfassung

Häufigkeit und Inzidenz: Karzinoide sind eine sehr seltene Neoplasie mit 0,5–2% alle Neoplasien. Die jährliche Neuerkrankungen beträgt 1–2 pro 100 000. Dies bedeutet, daß z. B. 1993 in den USA 2500 neue Fälle registriert wurden. Regionale Unterschiede sind nicht dokumentiert.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 54.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  • Brennan MF (1985) Cancer of the endocrine system. In: De Vita VI et al. (eds) Cancer. Principles and practice of oncology. Lippincott, Philadelphia, pp 1223–1227

    Google Scholar 

  • Capella C, Heitz PU, Höfler H et al. (1994) Revised classification of neuroendo- crine tumors of the lung, pnacreas and gut. Digestion 55 [Suppl 3]: 11–23

    Article  PubMed  Google Scholar 

  • De Vries EG, Eriksson B, Fiasse R et al. (1996) Multi-Center-Study investigates efficacy and safety of lanreotide (LAR) in patients with gastrointestinal neuroendocrine tumors and hormon related symptoms. Proc Am Soc Clin Oncol 15:abstract 414

    Google Scholar 

  • Engstrom PF, Lavin P et al. (1984) Streptozotocin plus 5-Fluoruracil vs. Adriamycin for metastatic carcinoid tumor. J Clin Oncol 2: 1255ff.

    PubMed  CAS  Google Scholar 

  • Frisen SR (1982) Tumors of the endocrine pancreas. N Engl J Med 306: 580–590

    Article  Google Scholar 

  • Godwin DJ (1975) Carcinoid tumors: An analysis of 2, 837 cases. Cancer 36: 560–569

    Google Scholar 

  • Haskell CM, Tompkins RK (1985) Carcinoid tumors. In: Haskell CM (ed) Cancer Treatment. Saunders, Philadelphia, pp 585–594

    Google Scholar 

  • Moertel CG (1984) Treatment of the carcinoid tumor and the malignant carcinoid syndrome. J Clin Oncol 1: 727–740

    Google Scholar 

  • Moertel CG, Rubin J, Kvols LK (1989) Therapy of metastatic carcinoid tumor and the malignant carcinoid syndrome with recombinant leukocyte A interferon. J Clin Oncol 7: 865–868

    PubMed  CAS  Google Scholar 

  • Moertel CG, Kvols LK, O’Connell M, Rubin J (1991) Treatment of neuroendocrine carcinomas with combined etoposide and cisplatin: evidence of major therapeutic activity in anaplastic variants of these neoplasms. Cancer 68: 227–232

    Article  PubMed  CAS  Google Scholar 

  • Moertel CG, Johnson CM, McKusick MA et al. (1994) The management of patients with advanced carcinoid tumors and islet cell carcinomas. Ann Intern Med 120: 302–309

    Article  PubMed  CAS  Google Scholar 

  • Öberg K (1996) Neuroendocrine gastrointestinal tumors. Ann Oncol 7: 453–463

    Article  PubMed  Google Scholar 

  • Schöber C, Schmoll E, Schmoll HJ (1992) Antitumour effect and symptomatic control with interferon alpha 2b in patients with endocrine active tumours. Eur J Cancer 28 A (10): 1664–1666

    Google Scholar 

  • Sisson JC, Shapiro B, Bierwaltes WH et al. (1984) Radiopharmaceutical treatment of malignant pheochromocytom. J Nucl Med 25: 197–206

    PubMed  CAS  Google Scholar 

  • Taal BG, Hoefnagel CA, Olmos RAV et al. (1996) Effect of Meta-Jodo-Benzyl-Guanidine in metastatic carcinoid tumors. J Clin Oncol 14: 1829–1836

    PubMed  CAS  Google Scholar 

  • Weil C (1985) Gastroenteropancreatic endocrine tumors. Klin Wochenschr 63: 433–459

    Article  PubMed  CAS  Google Scholar 

Download references

Authors
  1. H. J. Schmoll
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. E. Schmoll
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. H. Dralle
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. R. Arnold
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Klinik und Poliklinik, Innere Medizin IV, Abteilung Hämatologie/Onkologie, Martin-Luther-Universität Halle-Wittenberg, Ernst-Grube-Straße 40, D-06120, Halle/Saale, Deutschland

    Hans-Joachim Schmoll (Direktor) (Direktor)

  2. Klinik und Poliklinik für Innere Medizin II, Klinikum der Friedrich-Schiller-Universität Jena, Erlanger Allee 101, D-07740, Jena, Deutschland

    Klaus Höffken (Direktor) (Direktor)

  3. Medizinischen Klinik II, Schwerpunkt Onkologie und Hämatologie, Humboldt-Universität, Universitätsklinikum Charité, Schumannstraße 20/21, D-10117, Berlin, Deutschland

    Kurt Possinger (Direktor) (Direktor)

Rights and permissions

Reprints and permissions

Copyright information

© 1997 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Schmoll, H.J., Schmoll, E., Dralle, H., Arnold, R. (1997). Karzinoide. In: Schmoll, HJ., Höffken, K., Possinger, K. (eds) Kompendium Internistische Onkologie. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-12175-7_42

Download citation

  • DOI: https://doi.org/10.1007/978-3-662-12175-7_42

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-60830-1

  • Online ISBN: 978-3-662-12175-7

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation